Nutex Health (NUTX) Depreciation & Amortization (CF) (2010 - 2026)

Nutex Health has disclosed Depreciation & Amortization (CF) across 17 years of filings, most recently posting $5.5 million for Q1 2026.

• Depreciation & Amortization (CF) for Q1 2026 came in at $5.5 million, up 7.86% year-over-year; the trailing twelve-month figure through Mar 2026 was $20.9 million (up 5.29% YoY), and the FY2025 annual result was $20.5 million, up 8.21% from the prior year.
• Depreciation & Amortization (CF) came in at $5.5 million for Q1 2026 at Nutex Health, up from $5.2 million in the prior quarter.
• In the past five years, Depreciation & Amortization (CF) ranged from a high of $5.5 million in Q1 2026 to a low of $2.4 million in Q1 2022.
• The 5-year median for Depreciation & Amortization (CF) is $4.7 million (2023), against an average of $4.5 million.
• Peak annual rise in Depreciation & Amortization (CF) reached 3642.52% in 2022, while the deepest fall reached 20.45% in 2022.
• Nutex Health's Depreciation & Amortization (CF) stood at $3.3 million in 2022, then soared by 43.13% to $4.7 million in 2023, then climbed by 12.77% to $5.3 million in 2024, then fell by 1.78% to $5.2 million in 2025, then climbed by 5.88% to $5.5 million in 2026.
• The last three Depreciation & Amortization (CF) figures came in at $5.5 million (Q1 2026), $5.2 million (Q4 2025), and $5.0 million (Q3 2025), per Business Quant data.